Modification of the blood-brain barrier: increased concentration and fate of enzymes entering the brain
- PMID: 284363
- PMCID: PMC382965
- DOI: 10.1073/pnas.76.1.481
Modification of the blood-brain barrier: increased concentration and fate of enzymes entering the brain
Abstract
The blood-brain barrier of rats was opened reversibly by infusing a hyperosmotic solution of arabinose into the external carotid artery. Permeability was increased maximally in the first 15 min and remained slightly elevated at 1 hr. Osmotic barrier opening significantly increased brain uptake of intravenously injected alpha-mannosidase (alpha-D-mannoside mannohydrolase, EC 3.2.1.2.4) (derived from human placenta) and horseradish peroxidase (donor:hydrogen-peroxide oxidoreductase, EC 1.11.1.7). By injection of 4 X 10(5) units of alpha-mannosidase into an animal, brain activity rose to about twice the normal control activity of the enzyme. After 30 min, activity of administered enzyme in the extracellular space of the brain was calculated to be 30% of the serum concentration. Biochemical and histological studies with horseradish peroxidase showed that exogenously administered enzyme entered the brain extracellular space immediately after barrier opening and was incorporated within neuronal lysosomal packets during the next 24 hr. Measurable peroxidase activity was found in brain as much as 72 hr after osmotic treatment. The results demonstrate that the blood-brain barrier can be reversibly opened to enzymes, that a glycoprotein enzyme is incorporated into neuronal lysosomes, and that the brain may now be considered a potential target for enzyme replacement therapy in heritable metabolic disorders.
Similar articles
-
Osmotic opening of the blood-brain barrier.Ciba Found Symp. 1978 Mar;(56):237-55. doi: 10.1002/9780470720370.ch13. Ciba Found Symp. 1978. PMID: 97064
-
Hyperosmotic arabinose solutions open the tight junctions between brain capillary endothelial cells in tissue culture.Brain Res. 1984 Jun 8;302(2):383-6. doi: 10.1016/0006-8993(84)90254-3. Brain Res. 1984. PMID: 6733518
-
Access of enzymes to brain following osmotic alteration of the blood-brain barrier.Birth Defects Orig Artic Ser. 1980;16(1):195-205. Birth Defects Orig Artic Ser. 1980. PMID: 6256018 No abstract available.
-
Quantitative aspects of reversible osmotic opening of the blood-brain barrier.Am J Physiol. 1980 May;238(5):R421-31. doi: 10.1152/ajpregu.1980.238.5.R421. Am J Physiol. 1980. PMID: 7377381
-
Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.Histol Histopathol. 2004 Apr;19(2):535-64. doi: 10.14670/HH-19.535. Histol Histopathol. 2004. PMID: 15024715 Review.
Cited by
-
The clinical management of Type 2 Gaucher disease.Mol Genet Metab. 2015 Feb;114(2):110-122. doi: 10.1016/j.ymgme.2014.11.008. Epub 2014 Nov 14. Mol Genet Metab. 2015. PMID: 25435509 Free PMC article. Review.
-
Mannitol-facilitated CNS entry of rAAV2 vector significantly delayed the neurological disease progression in MPS IIIB mice.Gene Ther. 2009 Nov;16(11):1340-52. doi: 10.1038/gt.2009.85. Epub 2009 Jul 9. Gene Ther. 2009. PMID: 19587708 Free PMC article.
-
Studies on the permeability of the blood-brain barrier in experimental diabetes.Diabetologia. 1986 Jan;29(1):58-62. doi: 10.1007/BF02427282. Diabetologia. 1986. PMID: 2937677
-
Uptake of mannose-terminal glucocerebrosidase in cultured human cholinergic and dopaminergic neuron cell lines.Neurochem Res. 2002 Apr;27(4):325-30. doi: 10.1023/a:1014915430398. Neurochem Res. 2002. PMID: 11958535
-
A clinical trial of fibroblast transplantation for the treatment of mucopolysaccharidoses.J Inherit Metab Dis. 1983;6(2):62-81. doi: 10.1007/BF02338973. J Inherit Metab Dis. 1983. PMID: 6410119 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials